← Browse by Condition
Medical Condition

non small cell lung cancer stage iii

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 2
NCT06908070 Phase 4
Recruiting

Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab

Enrollment
38 pts
Location
Netherlands
Sponsor
Idris Bahce
View Trial →
NCT05398094 Phase 2
Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Enrollment
19 pts
Location
Spain
Sponsor
Fundación GECP
View Trial →
NCT06634199
Recruiting

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Enrollment
50 pts
Location
Spain
Sponsor
Fundación GECP
View Trial →
NCT04585477 Phase 2
Recruiting

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

Enrollment
80 pts
Location
United States
Sponsor
Stanford University
View Trial →